Literature DB >> 35831502

Within-host evolution of a gut pathobiont facilitates liver translocation.

Yi Yang1, Mytien Nguyen1, Varnica Khetrapal1, Nicole D Sonnert1,2, Anjelica L Martin1, Haiwei Chen1, Martin A Kriegel1,3,4, Noah W Palm5.   

Abstract

Gut commensal bacteria with the ability to translocate across the intestinal barrier can drive the development of diverse immune-mediated diseases1-4. However, the key factors that dictate bacterial translocation remain unclear. Recent studies have revealed that gut microbiota strains can adapt and evolve throughout the lifetime of the host5-9, raising the possibility that changes in individual commensal bacteria themselves over time may affect their propensity to elicit inflammatory disease. Here we show that within-host evolution of the model gut pathobiont Enterococcus gallinarum facilitates bacterial translocation and initiation of inflammation. Using a combination of in vivo experimental evolution and comparative genomics, we found that E. gallinarum diverges into independent lineages adapted to colonize either luminal or mucosal niches in the gut. Compared with ancestral and luminal E. gallinarum, mucosally adapted strains evade detection and clearance by the immune system, exhibit increased translocation to and survival within the mesenteric lymph nodes and liver, and induce increased intestinal and hepatic inflammation. Mechanistically, these changes in bacterial behaviour are associated with non-synonymous mutations or insertion-deletions in defined regulatory genes in E. gallinarum, altered microbial gene expression programs and remodelled cell wall structures. Lactobacillus reuteri also exhibited broadly similar patterns of divergent evolution and enhanced immune evasion in a monocolonization-based model of within-host evolution. Overall, these studies define within-host evolution as a critical regulator of commensal pathogenicity that provides a unique source of stochasticity in the development and progression of microbiota-driven disease.
© 2022. The Author(s), under exclusive licence to Springer Nature Limited.

Entities:  

Mesh:

Year:  2022        PMID: 35831502      PMCID: PMC9308686          DOI: 10.1038/s41586-022-04949-x

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   69.504


  55 in total

1.  Gut pathobionts underlie intestinal barrier dysfunction and liver T helper 17 cell immune response in primary sclerosing cholangitis.

Authors:  Nobuhiro Nakamoto; Nobuo Sasaki; Ryo Aoki; Kentaro Miyamoto; Wataru Suda; Toshiaki Teratani; Takahiro Suzuki; Yuzo Koda; Po-Sung Chu; Nobuhito Taniki; Akihiro Yamaguchi; Mitsuhiro Kanamori; Nobuhiko Kamada; Masahira Hattori; Hiroshi Ashida; Michiie Sakamoto; Koji Atarashi; Seiko Narushima; Akihiko Yoshimura; Kenya Honda; Toshiro Sato; Takanori Kanai
Journal:  Nat Microbiol       Date:  2019-01-14       Impact factor: 17.745

2.  Control of the expression of the manXYZ operon in Escherichia coli: Mlc is a negative regulator of the mannose PTS.

Authors:  J Plumbridge
Journal:  Mol Microbiol       Date:  1998-01       Impact factor: 3.501

3.  Adaptive Evolution within Gut Microbiomes of Healthy People.

Authors:  Shijie Zhao; Tami D Lieberman; Mathilde Poyet; Kathryn M Kauffman; Sean M Gibbons; Mathieu Groussin; Ramnik J Xavier; Eric J Alm
Journal:  Cell Host Microbe       Date:  2019-04-23       Impact factor: 21.023

4.  Translocation of a gut pathobiont drives autoimmunity in mice and humans.

Authors:  S Manfredo Vieira; M Hiltensperger; V Kumar; D Zegarra-Ruiz; C Dehner; N Khan; F R C Costa; E Tiniakou; T Greiling; W Ruff; A Barbieri; C Kriegel; S S Mehta; J R Knight; D Jain; A L Goodman; M A Kriegel
Journal:  Science       Date:  2018-03-09       Impact factor: 47.728

Review 5.  Host-microbiota interactions in immune-mediated diseases.

Authors:  William E Ruff; Teri M Greiling; Martin A Kriegel
Journal:  Nat Rev Microbiol       Date:  2020-05-26       Impact factor: 60.633

Review 6.  Pathobionts of the gastrointestinal microbiota and inflammatory disease.

Authors:  Janet Chow; Haiqing Tang; Sarkis K Mazmanian
Journal:  Curr Opin Immunol       Date:  2011-08-17       Impact factor: 7.486

7.  Long-term evolution and short-term adaptation of microbiota strains and sub-strains in mice.

Authors:  Bahtiyar Yilmaz; Catherine Mooser; Irene Keller; Hai Li; Jakob Zimmermann; Lars Bosshard; Tobias Fuhrer; Mercedes Gomez de Agüero; Nerea Fernandez Trigo; Heidi Tschanz-Lischer; Julien P Limenitakis; Wolf-Dietrich Hardt; Kathy D McCoy; Bärbel Stecher; Laurent Excoffier; Uwe Sauer; Stephanie C Ganal-Vonarburg; Andrew J Macpherson
Journal:  Cell Host Microbe       Date:  2021-03-03       Impact factor: 21.023

8.  Host-Specific Adaptive Diversification of Crohn's Disease-Associated Adherent-Invasive Escherichia coli.

Authors:  Wael Elhenawy; Caressa N Tsai; Brian K Coombes
Journal:  Cell Host Microbe       Date:  2019-01-22       Impact factor: 21.023

9.  Specific Eco-evolutionary Contexts in the Mouse Gut Reveal Escherichia coli Metabolic Versatility.

Authors:  João Barroso-Batista; Miguel F Pedro; Joana Sales-Dias; Catarina J G Pinto; Jessica A Thompson; Helena Pereira; Jocelyne Demengeot; Isabel Gordo; Karina B Xavier
Journal:  Curr Biol       Date:  2020-03-05       Impact factor: 10.834

10.  Genomic variation landscape of the human gut microbiome.

Authors:  Siegfried Schloissnig; Manimozhiyan Arumugam; Shinichi Sunagawa; Makedonka Mitreva; Julien Tap; Ana Zhu; Alison Waller; Daniel R Mende; Jens Roat Kultima; John Martin; Karthik Kota; Shamil R Sunyaev; George M Weinstock; Peer Bork
Journal:  Nature       Date:  2012-12-05       Impact factor: 49.962

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.